Previous 10 | Next 10 |
home / stock / opssf / opssf news
OPSENS ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIAL RESULTS Canada NewsWire Total Revenue up 37% - Medical Sales up 42% - Gross Margin 58% QUEBEC CITY, QC , Nov. 22, 2023 /CNW/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX...
INDEPENDENT PROXY ADVISORY FIRM ISS RECOMMENDS SHAREHOLDERS VOTE "FOR" OPSENS INC. PLAN OF ARRANGEMENT WITH HAEMONETICS CORPORATION Canada NewsWire All amounts in this press release are in Canadian dollars. Leading independent proxy advisor says cash offe...
OPSENS RECEIVES INTERIM ORDER AND FILES MANAGEMENT INFORMATION CIRCULAR IN CONNECTION WITH SPECIAL MEETING OF SHAREHOLDERS Canada NewsWire All amounts in this press release are in Canadian dollars. QUÉBEC CITY , Nov. 2, 2023 /CNW/ - OpS...
OPSENS ANNOUNCES THE POSITIVE CLINICAL RESULTS FROM THE SAFE-TAVI STUDY WITH SAVVYWIRE IN EUROPE Canada NewsWire QUEBEC CITY , Oct. 23, 2023 /CNW/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-...
OpSens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) in San Francisco October 23 - 26, 2023 Canada NewsWire OpSens Anticipates the Results of the SAFE-TAVI Clinical Study on October 25 O pSens to Host ...
2023-10-10 08:15:36 ET More on Haemonetics, Opsens, etc. Haemonetics' Fiscal Q1 2024: Blood, Sweat, And Stellar Gains Citi opens upside catalyst watch for Haemonetics ahead of earnings report Opsens reports Q3 results For further details see: Haemonetics ...
Haemonetics Corporation Announces Definitive Agreement to Acquire OpSens, Inc. PR Newswire Expands Haemonetics' Hospital portfolio with innovative fiber optic sensor technology for interventional cardiology Significant commercial synergies with Haemonetics' exist...
OPSENS SIGNS DEFINITIVE AGREEMENT FOR ITS ACQUISITION BY HAEMONETICS Canada NewsWire All amounts in this press release are in Canadian dollars. QUÉBEC CITY, QC , Oct. 10, 2023 /CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX...
2023-07-13 15:00:24 ET Opsens Inc. (OPSSF) Q3 2023 Earnings Conference Call July 13, 2023 11:00 a.m. ET Company Participants Louis Laflamme - President, Chief Executive Officer John Hannigan - Chief Financial Officer Joe Dorame - Managing Partner Conference...
OPSENS ANNOUNCES A THIRD CONSECUTIVE QUARTER OF RECORD REVENUES FOR THIRD QUARTER FISCAL 2023 Canada NewsWire Total Revenue up 31% - Medical Sales up 36% - Gross Margin up 780 basis points Conference call on the results today at 11:00 a.m. ET QUEB...
News, Short Squeeze, Breakout and More Instantly...
OncoSec Medical Incorporated (ONCSQ) is expected to report for quarter end 2023-10-31 Educational Development Corporation (EDUC) is expected to report for Q3 2024 Solitron Devices, Inc. (SODI) is expected to report for Q3 2024 Loop Industries Inc. (LOOP) is expected to report $-0.07 f...
Opsens Inc (OPSSF) is expected to report $-0.01 for Q1 2024
HAEMONETICS COMPLETES ACQUISITION OF OPSENS Canada NewsWire All amounts in this press release are in Canadian dollars. QUÉBEC CITY , Dec. 12, 2023 /CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF) , a medical...